inHEART has closed a round of EUR 3.7 million with Elaia and Aquitaine Science Transfert. These funds will be used to accelerate commercial development in Europe, access the US market, and advance its technology leadership with continued development of AI and numerical simulations of cardiac electrical activity.

https://www.prnewswire.com/news-releases/inheart-raises-4-2-million-to-improve-treatments-for-cardiac-arrhythmias-with-medical-imaging-artificial-intelligence-and-numerical-simulations-301086165.html?tc=eml_cleartime

‍